Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

104.00p
   
  • Change Today:
      0.80p
  • 52 Week High: 110.00
  • 52 Week Low: 73.00
  • Currency: UK Pounds
  • Shares Issued: 536.42m
  • Volume: 577,427
  • Market Cap: 557.88m
  • RiskGrade: 119

Alliance Pharma Overview

Alliance Pharma is in the pharma and biotech sector and is currently trading at 104.00p per share. In the last year Alliance Pharma's share price has ranged from 73.00p to 110.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 1.5% 1.6%
Div Cover 3.2 3.4
Op Mrgn 12.6% 22.5%
ROCE 26.1%  
Latest F'cast
P/E 20.0 18.6
PEG 8.5 2.5
Pr/Revenue 4.3 3.3
Pr/Book 2.0  
Latest F'cast
Revenue -4.3% 28.9%
PBT -58.1% 189.6%
EPS 2.4% 7.5%
DPS 200.4% 2.7%

Alliance Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-16 97.49 22.22 3.85p 12.3 1.4 +9% 1.21p 2.6%
31-Dec-17 101.64 28.29 5.33p 12.6 0.3 +38% 1.33p 2.0%
31-Dec-18 118.21 22.80 4.54p 14.8 n/a -15% 1.46p 2.2%
31-Dec-19 135.64 31.08 5.09p 16.5 1.4 +12% 0.54p 0.6%
31-Dec-20 129.80 13.02 5.21p 16.8 8.4 +2% 1.61p 1.8%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Alliance Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 167.30 37.70 5.60p 18.6 2.5 +8% 1.65p 1.6%
31-Dec-22 183.90 43.63 6.38p 16.3 1.2 +14% 1.67p 1.7%

Copyright © 2021 FactSet Research Systems Inc. All rights reserved.

Alliance Pharma Company Announcements

Total Voting Rights 04-Oct-2021 07:00 RNS
Grant of Options 01-Oct-2021 07:00 RNS
Interim Results 21-Sep-2021 07:00 RNS

Latest Alliance Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 104.00p
Change Today 0.80p
% Change 0.78 %
52 Week High 110.00
52 Week Low 73.00
Volume 577,427
Shares Issued 536.42m
Market Cap 557.88m
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
86.81% below the market average86.81% below the market average86.81% below the market average86.81% below the market average86.81% below the market average
45.10% above the sector average45.10% above the sector average45.10% above the sector average45.10% above the sector average45.10% above the sector average
Price Trend
62.32% above the market average62.32% above the market average62.32% above the market average62.32% above the market average62.32% above the market average
55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average55.56% above the sector average
Income
44.32% below the market average44.32% below the market average44.32% below the market average44.32% below the market average44.32% below the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average
Growth
9.2% below the market average9.2% below the market average9.2% below the market average9.2% below the market average9.2% below the market average
94.44% below the sector average94.44% below the sector average94.44% below the sector average94.44% below the sector average94.44% below the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Interim Final
Ex-Div 23-Dec-21 10-Jun-21
Paid 07-Jan-22 08-Jul-21
Amount 0.56p 1.07p

Trades for 15-Oct-2021

Time Volume / Share Price
16:48 17,928 @ 101.60p
16:48 3,200 @ 101.60p
16:35 197,578 @ 104.00p
16:29 371 @ 103.20p
16:29 733 @ 102.80p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page